Trial Profile
A 48 week, d/b [double-blind], d/d [double dummy], randomised, m/n [multinational], m/c [multicentre], 2 arm, p/g [parallel group] clinical study of fixed combination beclomethasone diproprionate + formoterol fumarate via PMDI [pressurised metered dose inhaler] with HFA-134a propellant vs budesonide + formoterol DPI [dry powder inhaler] vs formoterol DPI in stable severe COPD [chronic obstructive pulmonary disease]
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 07 Mar 2007
Price :
$35
*
At a glance
- Drugs Beclometasone/formoterol (Primary) ; Budesonide; Formoterol
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 07 Mar 2007 New trial record.